
Essa H.H and Abd-Alrahim A.M. Adjuvant intravesical instillation for primary intermediate and high-risk non-muscle invasive bladder cancer: BCG versus docetaxel. J Cancer Ther Res. 2016; 5:6. http://dx.doi.org/10.7243/2049-7962-5-6
Hoda H. Essa1* and Ahmed M. Abd-Alrahim2
*Corresponding author: Hoda H. Essa hodahassanessa@yahoo.com
1. Clinical Oncology Department, Faculty of Medicine, Egypt.
Essa H.H and Abd-Alrahim A.M. Adjuvant intravesical instillation for primary intermediate and high-risk non-muscle invasive bladder cancer: BCG versus docetaxel. J Cancer Ther Res. 2016; 5:6. http://dx.doi.org/10.7243/2049-7962-5-6
Copyright © 2015 Herbert Publications Limited. All rights reserved.